Results 101 to 110 of about 11,689 (208)

“More” Artificial mRNAs: Beyond the Art of Nature

Advanced Science, Volume 13, Issue 20, 9 April 2026.
Inspired by nature yet transcending it, synthetic mRNA is being redesigned beyond the canonical architecture. This review highlights emerging forms—circular, branched, and self‐amplifying mRNAs—that expand stability, persistence, and functional control, illustrating how artificial mRNA is evolving into a new medium for programmable biological ...
Yuanzhe Cui, Minami Fukui, Hirohisa Ohno, Hirohide Saito   +3 more
wiley   +1 more source

Summary of the Safety and Reactogenicity Results (all enrolled subjects, N = 120).

, 2016
Summary of the Safety and Reactogenicity Results (all enrolled subjects, N = 120).
Richard Nichols (604329), Eva Wagner (3165195), Alfred von Krempelhuber (724926), Jack T. Stapleton (93816), Philip Young (803781), Christine M. Hay (145141), Paul Chaplin (366377), Thomas P. Meyer (3165189), Richard N. Greenberg (3165183), Josef Weigl (3165186), Darja Schmidt (803780), Garth Virgin (724929), Thomas C. Marbury (3165180), Nathaly Arndtz-Wiedemann (724925), Eva Kreitmeir (3165198), Siegfried Röesch (3165192)   +15 more
core   +1 more source

Patient Diary Recorded Reactogenicity Following Dose 1 and Dose 2 of Vaccine Pooled Data.

, 2016
Patient Diary Recorded Reactogenicity Following Dose 1 and Dose 2 of Vaccine Pooled Data.
Colin Gelder (3599288), Richard Broughton (3587444), Corey P. Mallett (3599291), Rob Lambkin-Williams (444042), David He (306209), Anthony S. Gilbert (444037), Alex Mann (845560), John S. Oxford (444040), David Burt (3477137)   +8 more
core   +1 more source

Vaccine reactogenicity model data and code

, 2023
This code and data was used to generate all figures (with the exception of Figure S1) in the manuscript "A predictive model of vaccine reactogenicity using data from an in vitro human innate immunity assay system" by Pullen et al.
Robert Pullen
core   +1 more source

Immunogenicity and safety of the adult tbe vaccine «tick-e-vac»

Вопросы вирусологии, 2017
About 3,000 cases of TBE are registered annually in the Russian Federation. Vaccination is the main way to prevent the tick-borne encephalitis disease.
M. F. Vorovitch, G. B. Maikova, L. L. Chernokhaeva, V. V. Romanenko, A. V. Ankudinova, Yu. Kh. Khapchaev, G. G. Karganova, A. A. Ishmukhametov, S. G. Drozdov   +8 more
doaj   +1 more source

COVID-19 Vaccine Reactogenicity Among Young Children

JAMA Network Open
This cross-sectional study examines reactogenicity among children of participants in the Centers for Disease Control and Prevention COVID-19 Vaccine Pregnancy Registry from November 2022 to September 2023 to understand the frequency and types of reactions experienced.
Madni, Sabrina A., Strickland, Kieauna, Konrad, Victoria, Zauche, Lauren Head, Olson, Christine K., Sharma, Andrea J.   +5 more
openaire   +2 more sources

Safety Practices During Hymenoptera Venom Immunotherapy: Single‐Centre Experience With Protocolised Intravenous Cannulation and Adrenaline Usage

Allergy, Volume 81, Issue 6, Page 2212-2214, June 2026.
Callum McWaters, Nicole Weibel, Elizabeth Leahy, Samantha Chan, Kymble Spriggs   +4 more
wiley   +1 more source

Reactogenicity of Biomaterials as Studied by Biochemical, Morphological and Ultrastructural Techniques

, 1992
Reactogenicity is a characteristic of biocompatible materials that provokes the reparative and proliferative reaction of connective tissues, a compulsory stage of which is inflammation. Thus, reactogenicity studies should include experiments in vivo.
Kuzmina, Irina V., Sevastjanova, Natalya A., Ozolanta, Ivetta L., Dombrovska, Laimdota E., Slutskii, Leonid I.   +4 more
core  

THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS

, 2014
. The article presents results of a prospective randomized study of reactogenicity, safety and immunogenicity of the polysaccharide pneumococcal vaccine “Pneumo 23” in the group of medical workers.
I. V. Feldblum, V. V. Semerikov, N. A. Metelkina, V. V. Nikolenko, S. O. Golodnova   +4 more
core   +1 more source

Maximum systemic reactogenicity, prime vs boost, by treatment group.

, 2018
Bar graphs show the percentage of participants in each treatment group reporting the specified maximum severity during the reactogenicity period. Left panels (Prime) indicate the maximum severity over all 3 priming injections.
Magdalena E. Sobieszczyk (332353), M. Juliana McElrath (140060), Mary A. Allen (5774435), Shuying S. Li (262892), Gregory J. Wilson (2539195), David K. Clarke (5774447), Hong Van N. Tieu (5774438), Michael A. Egan (781415), Marnie L. Elizaga (102244), Ayuko Ota-Setlik (5774450), Theresa E. Latham (5774444), Ian Frank (10438), John H. Eldridge (781416), Nidhi K. Kochar (5774432), Brittany Sanchez (5774441), Christine Mhorag Hay (5774453), Drew Hannaman (221435), Kristen W. Cohen (106407), Rong Xu (296325)   +18 more
core   +1 more source